Risk-stratified PSA screening is bringing a once-abandoned test back into primary care
Dr. Dereck Mush, MD, MBA
Healthleap
Clinical AI that reads every inpatient record daily to flag undiagnosed conditions such as malnutrition and delirium.
What they do
Healthleap analyzes notes, labs, vitals and orders each morning and pushes risk scores into EHR workflows so care teams see who needs attention first. Founded in 2022 by siblings Josiah and Jemima Meyer, it raised $38M in combined funding: an $8M seed co-led by Sequoia Capital and First Round Capital and a $30M Series A led by Hummingbird Ventures.
The record
- Vertical
- Clinical AI
- Sub-segment
- Inpatient risk screening
- Product type
- Platform software
- Stage
- Series A
- Headquarters
- San Francisco, United States
- Region
- North America
- Founded
- 2022
- Total funding
- $38M raised
Notable investors: Hummingbird Ventures, Sequoia Capital, First Round Capital.
Also in Clinical AI
Related on The Signal
Dr. Dereck Mush, MD, MBA
Personalized Screening Versus Annual Mammography: What the Evidence Actually Compares
Dr. Dereck Mush, MD, MBA
Perinatal mental health screening is finally getting built into standard obstetric workflows
Dr. Dereck Mush, MD, MBA
The MCED Inflection Point: What Galleri's FDA Panel Backing Means for Cancer Screening
Dr. Dereck Mush, MD, MBA